Global data on blindness
Abstract
Globally, it is estimated that there are 38 million persons who are blind. Moreover, a further 110 million people have low vision and are at great risk of becoming blind. The main causes of blindness and low vision are cataract, trachoma, glaucoma, onchocerciasis, and xerophthalmia; however, insufficient data on blindness from causes such as diabetic retinopathy and age-related macular degeneration preclude specific estimations of their global prevalence. The age-specific prevalences of the major causes of blindness that are related to age indicate that the trend will be for an increase in such blindness over the decades to come, unless energetic efforts are made to tackle these problems. More data collected through standardized methodologies, using internationally accepted (ICD-10) definitions, are needed. Data on the incidence of blindness due to common causes would be useful for calculating future trends more precisely.
Similar articles
-
Causes of blindness and visual impairment in Latin America.Surv Ophthalmol. 2012 Mar-Apr;57(2):149-77. doi: 10.1016/j.survophthal.2011.07.002. Epub 2011 Dec 2. Surv Ophthalmol. 2012. PMID: 22137039 Review.
-
Estimation of prevalence and incidence rates and causes of blindness in Israel, 1998-2003.Isr Med Assoc J. 2006 Dec;8(12):880-1. Isr Med Assoc J. 2006. PMID: 17214111
-
[Synthesis of the blindness situation in the countries of the Organization for Cooperation and Coordination in the Control of Major Endemic Diseases].Sante. 1998 Mar-Apr;8(2):138-40. Sante. 1998. PMID: 9642738 French.
-
Causes of vision loss worldwide, 1990-2010: a systematic analysis.Lancet Glob Health. 2013 Dec;1(6):e339-49. doi: 10.1016/S2214-109X(13)70113-X. Epub 2013 Nov 11. Lancet Glob Health. 2013. PMID: 25104599 Review.
-
[The methodology and focus in blindness prevention from an epidemiologic point of view].Zhonghua Yan Ke Za Zhi. 1989 Nov;25(6):365-7. Zhonghua Yan Ke Za Zhi. 1989. PMID: 2627863 Chinese.
Cited by
-
Profiles and Clinical Characteristics of Newly Diagnosed Glaucoma in Urban Korea: A Multicenter Study.Korean J Ophthalmol. 2020 Oct;34(5):353-360. doi: 10.3341/kjo.2020.0033. Epub 2020 Oct 5. Korean J Ophthalmol. 2020. PMID: 33099556 Free PMC article.
-
Knowledge and Attitude Towards Corneal Donation: Saudi medical students' perspective.Sultan Qaboos Univ Med J. 2022 Feb;22(1):106-112. doi: 10.18295/squmj.4.2021.056. Epub 2022 Feb 28. Sultan Qaboos Univ Med J. 2022. PMID: 35299798 Free PMC article.
-
Improved systemic safety and risk-benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma.Graefes Arch Clin Exp Ophthalmol. 2006 Nov;244(11):1491-6. doi: 10.1007/s00417-006-0328-0. Epub 2006 Apr 21. Graefes Arch Clin Exp Ophthalmol. 2006. PMID: 16628416 Clinical Trial.
-
Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisation.Drugs. 2003;63(22):2521-54. doi: 10.2165/00003495-200363220-00016. Drugs. 2003. PMID: 14609361 Review.
-
The role of P2 receptors in controlling infections by intracellular pathogens.Purinergic Signal. 2007 Mar;3(1-2):83-90. doi: 10.1007/s11302-006-9039-6. Epub 2007 Jan 12. Purinergic Signal. 2007. PMID: 18404421 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases